Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Restricted Cash for Operating Activities of $150.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2016-11-10
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-12-31 was $22.64K, a 754733.33% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-06-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-03-31 was $2.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for fiscal 2015 was $22.65K, a 64.97% increase from fiscal 2014.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in restricted cash for operating activities for fiscal 2014 was $13.73K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2016-09-30 | $150.00K 10-Q · filed 2016-11-10 | |||
| 2015-12-31 | $22.64K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $22.64K derived: sum of 2 quarters · filed 2016-11-10 | $22.64K derived: sum of 3 quarters · filed 2016-11-10 | $22.65K 10-K · filed 2016-03-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $2.00 10-Q · filed 2016-11-10 | $5.00 derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $2.00 10-Q · filed 2016-08-12 | $5.00 derived: sum of 3 quarters · filed 2016-08-12 | |
| 2015-03-31 | $2.00 10-Q · filed 2016-05-13 | $5.00 derived: sum of 2 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $13.73K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | $13.72K 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |